Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRSS1 | P07477 | 8/20 | 0.60 |
| ▸ | F12 | P00748 | 4/20 | 0.60 |
| ▸ | TMPRSS2 | O15393 | 3/20 | 0.60 |
| ▸ | F2 | P00734 | 3/20 | 0.60 |
| ▸ | ST14 | Q9Y5Y6 | 3/20 | 0.60 |
| ▸ | F10 | P00742 | 2/20 | 0.60 |
| ▸ | PLG | P00747 | 2/20 | 0.60 |
| ▸ | CHRM2 | P08172 | 2/20 | 0.60 |
| ▸ | MAOA | P21397 | 2/20 | 0.60 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.60 |
| ▸ | ADRA1A | P35348 | 2/20 | 0.60 |
| ▸ | DRD3 | P35462 | 2/20 | 0.60 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.60 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.60 |
| ▸ | HRH3 | Q9Y5N1 | 2/20 | 0.60 |
| ▸ | MLNR | O43193 | 1/20 | 0.60 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.60 |
| ▸ | C1R | P00736 | 1/20 | 0.60 |
| ▸ | LMNA | P02545 | 1/20 | 0.60 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20008714 | 0.95 | PRSS1 (0.63) | PRSS1F12TMPRSS2F2ST14 | |
| SCHEMBL20008750 | 0.94 | F12 (0.55) | PRSS1F12TMPRSS2F2ST14 | |
| SCHEMBL20008755 | 0.88 | TMPRSS2 (0.66) | PRSS1TMPRSS2F2ST14F10 | |
| SCHEMBL18720302 | 0.88 | PRSS1 (0.60) | PRSS1F12TMPRSS2F2ST14 | |
| SCHEMBL20008753 | 0.87 | PRSS1 (0.63) | PRSS1F12TMPRSS2F2ST14 | |
| SCHEMBL31380450 | 0.84 | F12 (0.76) | PRSS1F12TMPRSS2F2ST14 | |
| SCHEMBL20008757 | 0.84 | F12 (0.51) | PRSS1F12TMPRSS2F2ST14 | |
| SCHEMBL20008711 | 0.83 | PRSS1 (0.67) | PRSS1TMPRSS2F2ST14F10 | |
| SCHEMBL20008743 | 0.82 | TMPRSS2 (0.57) | PRSS1TMPRSS2F2ST14F10 | |
| SCHEMBL20008744 | 0.82 | FTO (0.46) | PRSS1F12TMPRSS2F2ST14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180085366-A1 | OPIOID COMPOSITIONS RESISTANT TO OVERDOSE AND ABUSE | ELYSIUM THERAPEUTICS, INC. | 2018-03-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180085366-A1 | OPIOID COMPOSITIONS RESISTANT TO OVERDOSE AND ABUSE | OPRM1, OPRK1, OPRD1 | PRSS1 952/4885F12 3544/4885TMPRSS2 588/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.